Literature DB >> 18618225

Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma.

Kiran Musunuru1, Santosh Kesari.   

Abstract

We report a case of the paraneoplastic opsoclonus-myoclonus ataxia syndrome in a patient with non-small cell lung carcinoma, which represents a highly unusual association. The patient simultaneously manifested both severe neurologic symptoms and widely metastatic disease, complicating her treatment.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18618225      PMCID： PMC2652648          DOI： 10.1007/s11060-008-9650-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  11 in total

Review 1.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

2.  Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies.

Authors:  D J H McCabe; N C Turner; D Chao; A Leff; N A Gregson; H J Womersley; I Mak; G D Perkin; A H V Schapira
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

3.  Paraneoplastic brainstem encephalitis with tetraparesis in a patient with anti-Ri antibodies.

Authors:  Y A Rajabally; S Naz; D Farrell; R J Abbott
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

4.  Autoimmunity due to molecular mimicry as a cause of neurological disease.

Authors:  Michael C Levin; Sang Min Lee; Franck Kalume; Yvette Morcos; F Curtis Dohan; Karen A Hasty; Joseph C Callaway; Joseph Zunt; Dominic Desiderio; John M Stuart
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

5.  Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

Authors:  F A Luque; H M Furneaux; R Ferziger; M K Rosenblum; S H Wray; S C Schold; M J Glantz; K A Jaeckle; H Biran; M Lesser
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

Review 6.  Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration.

Authors:  K Musunuru; R B Darnell
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

7.  Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.

Authors:  Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

8.  Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system.

Authors:  R J Buckanovich; J B Posner; R B Darnell
Journal:  Neuron       Date:  1993-10       Impact factor: 17.173

9.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

Authors:  M L Albert; J C Darnell; A Bender; L M Francisco; N Bhardwaj; R B Darnell
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

10.  The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia.

Authors:  Y Y Yang; G L Yin; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205
View more
  10 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Acquired rhinophyma as a paraneoplastic manifestation of non-small cell lung cancer.

Authors:  Neven Rakusic; Denis Baricevic; Nevena Rakusic; Miroslav Samarzija; Marko Jakopovic; Marinka Baricevic
Journal:  Wien Klin Wochenschr       Date:  2012-04-14       Impact factor: 1.704

Review 3.  Eye Movement Disorders in Movement Disorders.

Authors:  Panagiotis Kassavetis; Diego Kaski; Tim Anderson; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

4.  Autoantigen discovery with a synthetic human peptidome.

Authors:  H Benjamin Larman; Zhenming Zhao; Uri Laserson; Mamie Z Li; Alberto Ciccia; M Angelica Martinez Gakidis; George M Church; Santosh Kesari; Emily M Leproust; Nicole L Solimini; Stephen J Elledge
Journal:  Nat Biotechnol       Date:  2011-05-22       Impact factor: 54.908

5.  Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer.

Authors:  Mark A Lewis; Lynn C Hartmann; Daniel H Lachance; Rafael E Jimenez
Journal:  Rare Tumors       Date:  2010-09-30

6.  Case Report: Opsoclonus-Myoclonus Syndrome Associated With Contactin-Associated Protein-Like 2 and Acetylcholine Receptor Autoantibodies in the Setting of Non-Small Cell Lung Carcinoma.

Authors:  Christian S Rosenow; Sara Dawit; Luca P Farrugia; Katharine A Henry Ma; Akanksha Sharma; Andrew McKeon; Alyx B Porter; Marie F Grill
Journal:  Neurohospitalist       Date:  2021-05-07

7.  Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.

Authors:  Bilal Gani Taib; Andrew J Kinshuck; Philip Milburn-McNulty; Lauren Fratalia; Leigh Forsyth; David Husband; Terry M Jones; Anu Jacob
Journal:  J Med Case Rep       Date:  2015-06-02

8.  Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients.

Authors:  Manoj Banjara; Chaitali Ghosh; Aaron Dadas; Peter Mazzone; Damir Janigro
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

9.  Clinical Profile, Prognostic Indicators, and Therapeutic Outcomes of Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome: A Single-Center Experience from South India.

Authors:  Karthik Muthusamy; Maya Thomas; Sangeetha Yoganathan; Sniya Valsa Sudhakar
Journal:  Ann Indian Acad Neurol       Date:  2019 Jul-Sep       Impact factor: 1.383

10.  "Dancing eye syndrome" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer.

Authors:  S Laroumagne; Xavier Elharrar; B Coiffard; J Plojoux; H Dutau; D Breen; P Astoul
Journal:  Case Rep Med       Date:  2014-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.